LYFE Capital
About
LYFE Capital LYFE Capital operates as a transpacific healthcare investment platform with $2B total AUM, anchored by the $935M Fund IV (2022). With 5 global offices including Menlo Park and Singapore, the fund invests across therapeutics/pharma, life science tools/diagnostics, and medtech. Across 43 companies over 11 years, they average 4 new investments annually with a track record of 20+ IPOs and 10+ M&As covering 14+ medical specialties. The exits demonstrate the thesis working across geograph
Industries
Stage focus
Series ASeries B+
Geography
USChinaSoutheast Asia
Notable investments
- Burning Rock Bio
- Pliant Therapeutics
- Cytek Biosciences
- Profound Bio
Raising from LYFE Capital?
I've worked with founders across the industrial stack. If LYFE Capital is on your list, I can help you map the introduction path, sharpen the narrative, and run a tight process.
Talk to Dan